MedWatch

Demant CEO: Ketchup effect could lead to above-average growth in 2022 and 2023

Hearing-aid demand accumulated during the Covid-19 pandemic could provide the sector with several golden years, foresees Demant CEO Søren Nielsen.

Photo: Demant / PR

Danish hearing aid company Demant has noted a strong market upswing in the first half of 2021, having rebounded from the very low levels of the same period last year when the coronavirus pandemic stalled the market and postponed patients' visits to audiology clinics.

In the second quarter of this year, the company saw the release of pent-up demand from the US market – a ketchup effect, so to speak – being that many hearing-impaired customers delayed their adoption of hearing aids.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs